Denali Therapeutics Inc. Company Information
Denali Therapeutics Inc.'s employee growth, exchange listings and data sources
Key Information
- Name: Denali Therapeutics Inc.
- Ticker: D2NL34
- Exchange: BOVESPA
- Founded: 2013
- Industry: Biotechnology
- Sector: Pharmaceuticals & Biotech
- Market Cap: US$3.950b
- Listing Market Cap: US$22.406b
- Shares Outstanding: 143.17m
- Website: https://www.denalitherapeutics.com
Number of Employees
Location
- Denali Therapeutics Inc.
- 161 Oyster Point Boulevard
- South San Francisco
- California
- 94080
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| 4DN | MUN (Boerse Muenchen) | Yes | Common Stock | DE | EUR | Dec 2017 |
| DNLI | NasdaqGS (Nasdaq Global Select) | Yes | Common Stock | US | USD | Dec 2017 |
| 4DN | DB (Deutsche Boerse AG) | Yes | Common Stock | DE | EUR | Dec 2017 |
| D2NL34 | BOVESPA (Bolsa de Valores de Sao Paulo) | BDR EACH 5 REPR 1 COM | BR | BRL | Jan 2022 |
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/10/21 11:18 |
| End of Day Share Price | 2024/09/12 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.